Cell Death Differ 23 , 369379 (2016)
[DOI] [PMC free article] [PubMed] [Google Scholar] 316.Shah SV, Baliga R, Rajapurkar M, Fonseca VA
Research indicates that approximately 50-60% of patients require doses above 1mg to achieve meaningful weight reduction
Semaglutide significantly improves glycemic control, with clinical trials of Ozempic demonstrating HbA1c reductions of 1.0-1.8% depending on dose and baseline A1c levels
The researchers suggested that it also appears to increase the resting basal metabolic rate (how many calories you burn even when not exercising) and excess metabolism after exercise, which may be responsible for reductions in visceral fat
Additionally, GLP-1 receptor agonists may directly reduce gallbladder emptying and motility, potentially contributing to bile stasis and gallstone formation independently of weight loss effects